FDA To Hold Drug Code Meeting, Extends Proposed Rule Comment Deadline
This article was originally published in The Tan Sheet
Executive Summary
FDA has planned a public meeting to discuss proposed changes to the National Drug Code (NDC) system in the agency's proposed rule on "Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs," according to a notice published in the Oct. 31 Federal Register
You may also be interested in...
FDA Listing Proposed Rule Would Add Burdens To Code System – Industry
If FDA starts assigning companies National Drug Code numbers as it has proposed, it would "undo needed flexibility" for industry, the Consumer Healthcare Products Association says
FDA Listing Proposed Rule Would Add Burdens To Code System – Industry
If FDA starts assigning companies National Drug Code numbers as it has proposed, it would "undo needed flexibility" for industry, the Consumer Healthcare Products Association says
FDA Listing Proposed Rule Would Add Burdens To Code System – Industry
If FDA starts assigning companies National Drug Code numbers as it has proposed, it would "undo needed flexibility" for industry, the Consumer Healthcare Products Association says